- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06424730
Team Based Equity Conscious Telemedicine Approach to Hypertension
April 22, 2025 updated by: Wake Forest University Health Sciences
Team Based Equity Conscious Telemedicine Approach to Improve Hypertension Among Black Patients
The purpose of study is to understand the different factors (patient, societal, provider, clinic, health system) relevant in recruitment and participation of patients in Team Based Equity Conscious Telemedicine Approach to Improve Hypertension clinical trial.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Black patients suffer disproportionate hypertension (HTN) burden with worse control, resulting in HTN-related mortality rates twice those observed in non-Hispanic White patients.
Contextually informed care approach is urgently needed in Black patients for HTN management.
This study will evaluate multi-level barriers and facilitators for recruitment and participation of Black patients in a Team Based Equity Conscious Telemedicine Approach to Improve Hypertension (TET-HTN) clinical trial.
This study will also evaluate the feasibility of TET-HTN intervention in a randomized comparison with usual clinic-based hypertension care approach.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- African American or Black
- Patients with last clinic systolic Blood Pressure >140 mmHg or diastolic Blood Pressure >90 mmHg or both
Exclusion Criteria:
- Unable to read or speak English
- diminished ability to measure home BP (dementia, or psychosis)
- acute health changes in past 3 months increasing chance of BP instability (hospitalization);
- terminal illness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Interview Group
Black patients or their family members; Black community faith leaders; primary care providers and research coordinators
|
One audio-recorded interview with the participants lasting about 30-minutes
Other Names:
|
|
Experimental: Team based Equity conscious Telemedicine Hypertension (TET-HTN) intervention
Black patients with systolic blood pressure >140 mmHg on the last two clinic visits plus baseline systolic blood pressure >130 mmHg - deliver the TET-HTN intervention over six months
|
Will provide blood pressure monitor connected to a telehealth application.
Patients will be asked to measure home blood pressure once daily.
Will intensify medications as needed based on blood pressure measurement.
Trained nurses or pharmacists will provide 4 self-management telephone calls (up to 30 minutes per call) to patients to address hypertension knowledge, medication adherence, healthy eating, physical activity, weight management, stress management, tobacco and alcohol use, and sleep apnea (with referrals if needed).
Will support needs relevant in blood pressure control using locally available resources via community health worker and social workers.
Other Names:
|
|
Other: Usual Care
Black patients with systolic blood pressure >140 mmHg on the last two clinic visits plus baseline systolic blood pressure >130 mmHg - usual clinic based hypertension care using routinely available clinic services including community health worker/social worker.
Clinicians can offer self-management support (e.g., dietician referral) or recommend a home blood pressure monitor.
These activities mirror current primary care practice.
|
Usual clinic based hypertension care using routinely available clinic services including community health worker/social worker.
Clinicians can offer self-management support (e.g., dietician referral) or recommend a home blood pressure monitor.
These activities mirror current primary care practice.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barriers / Facilitators for Recruitment
Time Frame: Day 1
|
Evaluate multi-level barriers and facilitators for recruitment and participation of Black patients in a Team based Equity conscious Telemedicine (TET-HTN) clinical trial - will be reported as themes from thematic analysis of qualitative data
|
Day 1
|
|
Feasibility of Telemedicine Approach - Proportion of Subjects
Time Frame: Month 6
|
Evaluate the feasibility of Team Based Equity Conscious Telemedicine Hypertension intervention in a randomized comparison with usual clinic-based hypertension care.
Feasibility will be measured using the proportion of patients screened, eligible, agree to participate and decline.
|
Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Medication adherence
Time Frame: Month 6
|
Medication adherence using the Proportion of Days Covered
|
Month 6
|
|
Change in Blood Pressure
Time Frame: Month 6
|
Changes in Systolic and Diastolic Blood Pressure
|
Month 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Emergency Department and Urgent Care Visits
Time Frame: Month 6
|
Number of clinic, urgent care and emergency department visits
|
Month 6
|
|
Number of Subjects using Blood Pressure Monitors
Time Frame: Month 6
|
Patient self-reported home BP monitor use
|
Month 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yashashwi Pokharel, MD, MSCR, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2024
Primary Completion (Actual)
September 20, 2024
Study Completion (Actual)
September 20, 2024
Study Registration Dates
First Submitted
May 16, 2024
First Submitted That Met QC Criteria
May 16, 2024
First Posted (Actual)
May 22, 2024
Study Record Updates
Last Update Posted (Actual)
April 25, 2025
Last Update Submitted That Met QC Criteria
April 22, 2025
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00113617
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Feasibility Interview
-
University Hospital, ToulouseTerminated
-
West University of TimisoaraUniversity of BergenCompletedDepression | Anxiety Disorders | Mental Health Issue | Well-BeingRomania
-
University of Illinois at ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...TerminatedType 2 Diabetes | Self-regulationUnited States
-
Ottawa Hospital Research InstituteUnknown
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern...RecruitingObesity | Binge-Eating Disorder | Binge EatingUnited States
-
University of BelgradeActive, not recruiting
-
Imperial College LondonImperial College Healthcare NHS TrustCompletedCerebrovascular AccidentUnited Kingdom
-
Boston Medical CenterNortheastern UniversityCompletedDepression | Chronic Pain | Chronic Illness | Comorbid DepressionUnited States
-
Stanford UniversityCompletedAging | Virtual Reality | Serious Illness | Bucket ListUnited States
-
University of British ColumbiaCanadian Cancer Society (CCS)Completed